Jim Cramer's Stop Trading! Cool Cabela's

Cabela's (CAB Quote - Cramer on CAB - Stock Picks) and Archer Daniels (ADM Quote - Cramer on ADM - Stock Picks) look like good buys right now, Jim Cramer said Monday on CNBC's "Stop Trading!" segment.

Cramer said he likes outdoor goods retailer Cabela's because hunting has gotten more affordable again with the recent decline in gasoline prices. One indication that the duck blinds are back in the game is Alliant Techsystems' (ATK Quote - Cramer on ATK - Stock Picks) recent conference-call comment that "hunting bullets are off the charts," Cramer said.

Cramer also likes Archer Daniels, which he called a fast-growing agricultural name that trades at a discount to rivals' price-to-earnings multiples. He said the Decatur, Ill., company is growing at 10% a year but trading at only 13 times earnings estimates, while rival Bunge(BG Quote - Cramer on BG - Stock Picks) is growing at the same rate but fetches a 20 multiple. "Both have soybeans," Cramer noted.

Cramer wasn't positive on Pfizer (PFE Quote - Cramer on PFE - Stock Picks), which he called "Bristol-Myers (BMY Quote - Cramer on BMY - Stock Picks) all over again" in the wake of this weekend's cholesterol-drug debacle.

Cramer castigated Pfizer's management for what he called its "hype" of the torcetrapib cholesterol-regulating drug. Pfizer pulled development of the drug this weekend after study data showed users were dying more often than nonusers. Cramer questioned Pfizer's promotion of the drug, which he said the New York company likened to "the greatest thing since sliced bread."

"There are three things Pfizer is good at," Cramer said, calling the stock a "$25 bond with no upside." He said the three things are "issuing press releases, screaming at the media" and "blaming the system."

Luckily, "all three could come in handy" in the wake of the torcetrapib blowup, Cramer said, adding, "Pfizer, God love ya."